Julie Le Naour

Villejuif, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Lysosomal membrane permeabilization enhances the anticancer effects of POLR1 (RNA polymerase I) transcription inhibitors.

Lysosomal membrane permeabilization enhances the anticancer effects of POLR1 (RNA polymerase I) transcription inhibitors.

Journal: Autophagy
Published: June 18, 2025

Inhibition of MAPK p38α overcomes the cancer immunosurveillance defect caused by FPR1 loss-of-function mutation.

Inhibition of MAPK p38α overcomes the cancer immunosurveillance defect caused by FPR1 loss-of-function mutation.

Journal: Cell reports. Medicine
Published: March 21, 2025

Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesis.

Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesis.

Journal: Oncoimmunology
Published: July 26, 2023

A Chemically Defined TLR3 Agonist with Anticancer Activity.

A Chemically Defined TLR3 Agonist with Anticancer Activity.

Journal: Oncoimmunology
Published: June 30, 2023

Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancer.

Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancer.

Journal: Oncoimmunology
Published: March 27, 2023

Trial watch: Toll-like receptor ligands in cancer therapy.

Trial watch: Toll-like receptor ligands in cancer therapy.

Journal: Oncoimmunology
Published: March 06, 2023

A loss-of-function polymorphism in ATG16L1 compromises therapeutic outcome in head and neck carcinoma patients.

A loss-of-function polymorphism in ATG16L1 compromises therapeutic outcome in head and neck carcinoma patients.

Journal: Oncoimmunology
Published: April 28, 2022

Local anesthetics elicit immune-dependent anticancer effects.

Local anesthetics elicit immune-dependent anticancer effects.

Journal: Journal for immunotherapy of cancer
Published: March 22, 2022

Trial watch: intratumoral immunotherapy.

Trial watch: intratumoral immunotherapy.

Journal: Oncoimmunology
Published: October 22, 2021

Improved Swiss-rolling method for histological analyses of colon tissue.

Improved Swiss-rolling method for histological analyses of colon tissue.

Journal: MethodsX
Published: October 05, 2021

A major genetic accelerator of cancer diagnosis: rs867228 in FPR1.

A major genetic accelerator of cancer diagnosis: rs867228 in FPR1.

Journal: Oncoimmunology
Published: January 25, 2021

No impact of cancer and plague-relevant FPR1 polymorphisms on COVID-19.

No impact of cancer and plague-relevant FPR1 polymorphisms on COVID-19.

Journal: Oncoimmunology
Published: December 21, 2020
Showing 1-12 of 22

Last Updated: 09/26/2026